These CD8+ Tregs are usually reported to be decreased in SLE patients or favored for SLE therapy.22, 23 We previously reported that CD8+CD103+ Tregs generated ex vivo with TGF-β were notable for their potent suppressive capacity. Here, TGFB1 is linked to systemic lupus erythematosus.